The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions

Summary

The plasma membrane electron transport is crucial for blood coagulation and thrombosis, since reactive oxygen species and thiol changes, generated by plasma membrane redox reactions, modulate activation of platelets, as well as their interaction with leukocytes. Several antioxidants are linked to this system; thus, platelets are also able to counterbalance radical production and to regulate thrombus growth. Aim of this review is to give an update on the plasma membrane redox system in platelets, as well as on its role in platelet functions and leukocyte-platelet crosstalk.

Keywords

Platelets - plasma membrane redox system - NAD(P)H oxidase - ubiquinone - antioxidant vitamins

• References

• 1 Del Principe D, Mancuso G, Menichelli A. et al. Production of hydrogen peroxide in phagocyting human platelets: an electron microscopic cytochemical demonstration. Biol Cell 1980; 38: 135-140.
• 2 Finazzi-Agrò A, Menichelli A, Persiani M. et al. Hydrogen peroxide release from human blood platelets. Biochim Biophys Acta 1982; 718: 21-25.
• 3 Bakdash N, Williams MS. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med 2008; 45: 158-166.
• 4 Del Principe D, Mancuso G, Menichelli A. et al. Oxygen consumption in platelets of newborn infants before and after stimulation by thrombin. Thromb Haemost 1976; 35: 712-716.
• 5 Krötz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988-1996.
• 6 Freedman JE. Oxidative Stress and Platelets. Arterioscler Thromb Vasc Biol 2008; 28: 11-16.
• 7 Berridge MV, Tan AS. High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. Antioxid Redox Signal 2000; 2: 231-242.
• 8 VanDuijn MM, Van der Zee J, Van den Broek PJ. The ascorbate-driven reduction of extracellular ascorbate free radical by the erythrocyte is an electrogenic process. FEBS Lett 2001; 491: 67-70.
• 9 Arroyo A, Kagan VE, Tyurin VA. et al. NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Antioxid Redox Signal 2000; 2: 251-262.
• 10 Ly JD, Lawen A. Transplasma membrane electron transport: enzymes involved and biological function. Redox Rep 2003; 8: 3-21.
• 11 Geiszt M, Leto TL. The Nox family of NAD(P)H oxidases: host defense and beyond. J Biol Chem 2004; 279: 51715-51718.
• 12 Cave AC, Brewer AC, Narayanapanicker A. et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
• 13 O’Donnell VB, Smith GC, Jones OT. Involvement of phenyl radicals in iodonium inhibition of flavoenzymes. Mol Pharmacol 1994; 46: 778-785.
• 14 Heumüller S, Wind S, Barbosa-Sicard E. et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008; 51: 211-217.
• 15 Seno T, Inoue N, Gao D. et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001; 103: 399-409.
• 16 Zielinski T, Wachowicz B, Saluk-Juszczak J. et al. The generation of superoxide anion in blood platelets in response to different forms of Proteus mirabilis lipopolysaccharide: effects of staurosporin, wortmannin, and indomethacin. Thromb Res 2001; 103: 149-155.
• 17 White JG. Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system. Platelets 2005; 16: 121-131.
• 18 Krötz F, Sohn HY, Gloe T. et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002; 100: 917-924.
• 19 Begonja AJ, Gambaryan S, Geiger J. et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 2005; 106: 2757-2760.
• 20 Carnevale R, Pignatelli P, Lenti L. et al. LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 2007; 21: 927-934.
• 21 Chlopicki S, Olszanecki R, Janiszewski M. et al. Functional role of NADPH oxidase in activation of platelets. Antioxid Redox Signal 2004; 6: 691-698.
• 22 Peter AD, Morrè DJ, Morrè DM. A light-responsive and periodic NADH oxidase activity of the cell surface of tetrahymena and of human buffy coat cells. Antioxid Redox Signal 2000; 2: 289-300.
• 23 Morré DJ, Morré DM. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res 2003; 37: 795-808.
• 24 Morré DJ, Chueh PJ, Lawler J. et al. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfidethiol oxidoreductase with protein disulfidethiol interchange activity. J Bioenerg Biomembr 1998; 30: 477-487.
• 25 Irani K, Pham Y, Coleman LD. et al. Priming of platelet α_IIbβ₃ by oxidants is associated with tyrosine phosphorylation of β3. Arterioscler Thromb Vasc Biol 1998; 18: 1698-1706.
• 26 Lahav J, Jurk K, Hess O. et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100: 2472-2478.
• 27 Essex DW, Li M, Feinman RD. et al. Platelet surface glutathione reductase-like activity. Blood 2004; 104: 1383-1385.
• 28 Chen K, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood 1992; 79: 2226-2228.
• 29 Essex DW, Chen K, Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 1995; 86: 2168-2173.
• 30 Jordan PA, Stevens JM, Hubbard GP. et al. A role for the thiol isomerase protein ERP5 in platelet function. Blood 2005; 105: 1500-1507.
• 31 Lahav J, Gofer-Dadosh N, Luboshitz J. et al. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett 2000; 475: 89-92.
• 32 Lahav J, Wijnen EM, Hess O. et al. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood 2003; 102: 2085-2092.
• 33 Manickam N, Sun X, Li M. et al. Protein disulphide isomerase in platelet function. Br J Haematol 2008; 140: 223-229.
• 34 Janiszewski M, Lopes LR, Carmo AO. et al. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 2005; 280: 40813-40819.
• 35 Lyles MM, Gilbert HF. Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: dependence of the rate on the composition of the redox buffer. Biochemistry 1991; 30: 613-619.
• 36 Savini I, Catani MV, Arnone R. et al. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med 2007; 42: 608-616.
• 37 Takajo Y, Ikeda H, Haramaki N. et al. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol 2001; 38: 1320-1327.
• 38 McVeigh GE, Hamilton P, Wilson M. et al. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate. Circulation 2002; 106: 208-213.
• 39 Wells WW, Xu DP, Yang YF. et al. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem 1990; 265: 15361-15364.
• 40 Freedman JE, Farhat JH, Loscalzo J. et al. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94: 2434-2440.
• 41 Liu M, Wallmon A, Olsson-Mortlock C. et al. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003; 77: 700-706.
• 42 Taccone-Gallucci M, Lubrano R, Del Principe D. et al. Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation. Nephrol Dial Transplant 1989; 4: 975-978.
• 43 Blache D. Involvement of hydrogen and lipid peroxides in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol 1995; 268: H679-H685.
• 44 Del Principe D, Menichelli A, De Matteis W. et al. Hydrogen peroxide is an intermediate in the platelet activation cascade triggered by collagen, but not by thrombin. Thromb Res 1991; 62: 365-375.
• 45 Rosado JA, Nunez AM, Lopez JJ. et al. Intracellular Ca2+ homeostasis and aggregation in platelets are impaired by ethanol through the generation of H2O2 and oxidation of sulphydryl groups. Arch Biochem Biophys 2006; 452: 9-16.
• 46 May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008; 28: s5-s10.
• 47 Cerletti C, Evangelista V, de Gaetano G. P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999; 82: 787-793.
• 48 Williams LA, Martin-Padura I, Dejana E. et al. Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol 1999; 36: 1175-1188.
• 49 Lösche W, Dressel M, Krause S. et al. Contact-induced modulation of neutrophil elastase secretion and phagocytic activity by platelets. Blood Coagul Fibrinolysis 1996; 7: 210-213.
• 50 Li N, Hu H, Lindqvist M. et al. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000; 20: 2702-2708.
• 51 Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99: 480-486.
• 52 Del Principe D, Menichelli A, Di Giulio S. et al. Stimulated platelets release factor(s) affecting the in vitro response of human polymorphonuclear cells. J Leukoc Biol 1990; 48: 7-14.
• 53 Jancinová V, Drábiková K, Nosál’ R. et al. Inhibition of FMLP-stimulated neutrophil chemiluminescence by blood platelets increased in the presence of the serotonin-liberating drug chloroquine. Thromb Res 2003; 109: 293-298.
• 54 Del Principe D, Frega G, Palumbo G. Platelet-leukocyte interactions: platelets possess an antioxidant armamentarium. Thromb Haemost 2003; 90: 759-760.
• 55 Janiszewski M, Carmo AO, Pedro MA. et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit Care Med 2004; 32: 818-825.
• 56 Stokes KY, Russell JM, Jennings MH. et al. Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. Free Radic Biol Med 2007; 43: 22-30.
• 57 Rodríguez-Alonso J, Montañez R, Rodríguez-Caso L. et al. Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr 2008; 40: 45-51.
• 58 Wang JS, Lin HY, Cheng ML. et al. Chronic intermittent hypoxia modulates eosinophil- and neutrophil-platelet aggregation and inflammatory cytokine secretion caused by strenuous exercise in men. J Appl Physiol 2007; 103: 305-314.
• 59 Pittaluga M, Parisi P, Sabatini S. et al. Cellular and biochemical parameters of exercise-induced oxidative stress: relationship with training levels. Free Radic Res 2006; 40: 607-614.
• 60 Pignatelli P, Di Santo S, Buchetti B. et al. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB 2006; 20: 1082-1089.
• 61 Raghavan SA, Sharma P, Dikshit M. Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes. Thromb Res 2003; 110: 117-126.
• 62 Mabile L, Bruckdorfer KR, Rice-Evans C. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 1999; 147: 177-185.
• 63 Murohara T, Ikeda H, Otsuka Y. et al. Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: role of P-selectin. Circulation 2004; 110: 141-148.
• 64 Wang JS, Lin HY, Cheng ML. et al. Chronic intermittent hypoxia modulates eosinophil- and neutrophil-platelet aggregation and inflammatory cytokine secretion caused by strenuous exercise in men. J Appl Physiol 2007; 103: 305-314.
• 65 Amer J, Zelig O, Fibach E. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria. Exp Hematol 2008; 36: 369-377.
• 66 Amer J, Ghoti H, Rachmilewitz E. et al. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2006; 132: 108-113.
• 67 Morré DJ, Rodriguez-Aguilera JC, Navas P. et al. Redox modulation of the response of NADH oxidase activity of rat liver plasma membranes to cyclic AMP plus ATP. Mol Cell Biochem 1997; 173: 71-77.
• 68 Preissner KT. From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II). Thromb Haemost 2008; 99: 465.
• 69 Kannemeier C, Shibamiya A, Nakazawa F. et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. PNAS 2007; 104: 6388-6393.
• 70 Nakazawa F, Kannemeier C, Shibamiya A. et al. Extracellular RNA is a natural cofactor for the (auto-)activation of fctor VII-activating protease (FSAP). Biochem J 2005; 385: 831-838.
• 71 Bandziulis RJ, Swanson MS, Dreyfuss G. RNA-binding proteins as developmental regulators. Genes Dev 1989; 3: 431-437.
• 72 Pagni M, Ioannidis V, Cerutti L. et al. MyHits: a new interactive resource for protein annotation and domain identification. Nucleic Acids Res 2004; 32 Web Server issue W332-335.